Viewing Study NCT00382694

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:37 AM
Ignite Modification Date: 2025-12-28 @ 12:12 AM
Study NCT ID: NCT00382694
Status: UNKNOWN
Last Update Posted: 2006-09-29
First Post: 2006-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients
Sponsor: Nordic Myeloma Study Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myeloma View
None Induction therapy View
None High-dose melphalan View
None Autologous stem cell support View
None Fludarabine View
None Cyclophosphamide View
None Dexamethasone View
None Safety View
None Toxicity View